The only effective treatments currently are procedural, and there are no available medications
Claims (15) Priority Applications (1) Applications Claiming Priority (2) Publications (2) Family ID=9369324 Family Applications (2) Family Applications After (1) Country Status (10) Cited By (6) Families Citing this family (1) Citations (1) Family Cites Families (5) 1988 1988-08-12 FR FR8810886A patent/FR2635264B1/en not_active Expired - Fee Related 1989 1989-08-01 CA CA000607172A patent/CA1341260C/en not_active Expired - Fee Related 1989-08-10 DE DE198989402257T patent/DE354848T1/en active Pending 1989-08-10 ES ES89402257T patent/ES2043062T3/en not_active Expired - Lifetime 1989-08-10 EP EP89402257A patent/EP0354848B1/en not_active Expired - Lifetime 1989-08-10 PT PT91430A patent/PT91430B/en not_active IP Right Cessation 1989-08-10 DE DE8989402257T patent/DE68903448T2/en not_active Expired - Fee Related 1989-08-10 AT AT89402257T patent/ATE82122T1/en not_active IP Right Cessation 1989-08-10 EP EP89909580A patent/EP0428608A1/en active Pending 1989-08-10 WO PCT/FR1989/000419 patent/WO1990001316A1/en not_active Ceased 1989-08-10 JP JP1508982A patent/JP2785989B2/en not_active Expired - Lifetime 1991 1991-09-27 GR GR90300149T patent/GR900300149T1/en unknown 1992 1992-12-21 GR GR920403006T patent/GR3006598T3/el unknown
Glutamyl hydrolase, on the other hand, converts MTX-PGs back into MTX
Mice and rats are commonly used in animal studies due to their small size, short reproductive cycle, and genetic similarity to humans
All IV therapy at OneMedicine is: Doctor-led Clinically prescribed Delivered in a regulated medical environment We may recommend baseline blood tests, including liver and kidney function, before intravenous treatment to ensure safety
407 RNA degradation strategies Owing to its intricate structure, RNA has a diverse array of cellular functions, including the regulation of gene expression, protein translation, and the cellular response to stimuli
